Eluminex Biosciences Closes $40+ Million Series B Financing To Continue The Development Of Innovative Ophthalmic Assets And Recombinant Human Collagen Technology
Amount Raised
$40 Million
Round Type
Series B
SuzhouBiotechnologyInvestors
Description
Eluminex Biosciences (Suzhou) Limited (Eluminex) officially announced today the closing of a Series B financing of over $40 million (USD). Financing was led by Cenova Capital with additional participation from Guangzhou Yuexiu Industrial Investment Fund Management, 3E Bioventures Capital, Oriza Holdings, and Series A investors.
Quick answer
Eluminex Biosciences raised $40 Million in a Series B round, dated February 27, 2023. Investors: Oriza Holdings, 3 E Bioventures Capital, Guangzhou Yuexiu Industrial Investment Fund Management and Cenova Capital. Eluminex Biosciences is based in Suzhou, Jiangsu, China.
- How much did Eluminex Biosciences raise?
- Eluminex Biosciences raised $40 Million in a Series B round on February 27, 2023.
- Who invested in Eluminex Biosciences?
- Oriza Holdings, 3 E Bioventures Capital, Guangzhou Yuexiu Industrial Investment Fund Management and Cenova Capital are named as investors in this round.
- What does Eluminex Biosciences do?
- Founded in February 2020, Eluminex Biosciences (Suzhou) Limited is a global biotechnology company focusing on ophthalmic diseases and recombinant human collagen technology.
- Where is Eluminex Biosciences based and how big is it?
- Eluminex Biosciences is based in Suzhou, Jiangsu, China.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Eluminex Biosciences that raised within 45 days of this round, from Fundz verified event records.
- Aer Therapeutics raised $36M (Series A) on April 13, 2023.
- OncoLize raised $1.7M (Seed) on April 13, 2023.
- Wheeler Bio raised $31M (Series A) on April 13, 2023.
- Neuromod Devices raised $33M (Funding Round) on April 13, 2023.
- ClinOne, Inc. raised an undisclosed amount (Series A) on April 13, 2023.
- Persist AI raised $4.9M (Seed) on April 13, 2023.
Who to call at Eluminex Biosciences, and when
A new round usually means Eluminex Biosciences is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Eluminex Biosciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Eluminex Biosciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Eluminex Biosciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Eluminex Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Funding Insights
What this usually meansEluminex Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.